BioXcel Therapeutics Inc. (BTAI)
NASDAQ: BTAI
· Real-Time Price · USD
3.79
0.22 (6.16%)
At close: Sep 05, 2025, 3:59 PM
3.88
2.37%
After-hours: Sep 05, 2025, 05:45 PM EDT
BioXcel Therapeutics Revenue
BioXcel Therapeutics reported an annual revenue of $2.27M, reflecting a 64.2% growth. For the quarter ending June 30, 2025, BioXcel Therapeutics generated $120K in revenue.
Revenue (ttm)
2.27M
Revenue Growth
64.2%
Price / Sales Ratio
6.69
Revenue / Employee
61.24K
Employees
37
Market Cap
22.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 2.27M | +64.20% |
| Dec 31, 2023 | 1.38M | +268.00% |
| Dec 31, 2022 | 375K | +Infinity% |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |